Pioglitazone, an in vitro inhibitor of CYP2C8 and CYP3A4, does not increase the plasma concentrations of the CYP2C8 and CYP3A4 substrate repaglinide
Lauri I. Kajosaari, Tiina Jaakkola, Pertti J. Neuvonen, Janne T. BackmanVolume:
62
Language:
english
Pages:
7
DOI:
10.1007/s00228-005-0093-8
Date:
March, 2006
File:
PDF, 164 KB
english, 2006